Login to Your Account

$400M Merger With Eli Lilly Boosts AME 50 Percent-Plus

By Randall Osborne

Monday, November 24, 2003
About two years after signing a partnership for protein optimization with Eli Lilly and Co. - and less than a week after filing its first investigational new drug application for a compound being developed in-house - Applied Molecular Evolution Inc. has agreed to merge with Lilly in a deal expected to be worth about $400 million, net of cash. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription